Plant ID: NPO14814
Plant Latin Name: Aristolochia contorta
Taxonomy Genus: Aristolochia
Taxonomy Family: Aristolochiaceae
NCBI TaxonomyDB:
266420
Plant-of-the-World-Online:
92854-1
Antiasthmatic; Antiseptic; Antitussive; Cancer; Expectorant; Sedative
Japan; China; Russia; South Africa
CDK2; | |
CA2; CA3; CA14; CA7; CA5A; CA4; CA6; CA12; CA9; CA1; CA5B; | |
ESR2; | |
HTT; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Protein Kinase | CDK2 | Cyclin-dependent kinase 2 | P24941 | CHEMBL301 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 6.747E-12 | 1.469E-08 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.836E-33 | 1.053E-28 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.695E-26 | 2.934E-22 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 2.186E-06 | 2.505E-03 | CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.466E-24 | 1.342E-20 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.091E-05 | 1.132E-02 | CA1, CA2 |
CC | GO:0043226; organelle | GO:0015030; Cajal body | 1.218E-05 | 1.206E-02 | CDK2, SMN1, SMN2 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 3.267E-05 | 2.964E-02 | CA2, CA7 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 4.787E-05 | 4.169E-02 | SMN1, SMN2 |
BP | GO:0023052; signaling | GO:0032230; positive regulation of synaptic transmission, GABAergic | 5.654E-05 | 4.560E-02 | CA2, CA7 |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 5.654E-05 | 4.560E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 2.989E-32 | 9.563E-31 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 1.703E-04 | 2.724E-03 | CA2, CA4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.633E-03 | 1.741E-02 | CA2, CYP3A4 |
09120 Genetic Information Processing | 09122 Translation | hsa03013 | RNA transport | 9.187E-03 | 7.350E-02 | SMN2, SMN1 |
09150 Organismal Systems | 09155 Excretory system | hsa04966 | Collecting duct acid secretion | 2.271E-02 | 1.295E-01 | CA2 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.438E-02 | 1.295E-01 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 3.840E-02 | 1.295E-01 | CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 4.819E-02 | 1.295E-01 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 5.708E-02 | 1.295E-01 | CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04971 | Gastric acid secretion | 6.110E-02 | 1.295E-01 | CA2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |